OXIS Stock News 0.0053 05/06/2014 08:57:58 Oxis Intl Inc (OX

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Oxis Intl Inc (OXIS) 0.0053 $OXIS

Cardiovascular Disease - Pipeline Review: Latest updates and review of key players
M2 - Wed Jan 09, 5:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/9szlks/cardiovascular) has announced the addition of Global Markets Direct's new report "Cardiovascular Disease - Pipeline Review, H2 2012" to their offering. This report provides information on the therapeutic development for Cardiovascular Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cardiovascular Disease. Cardiovascular Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Scope - A snapshot of the global therapeutic scenario for Cardiovascular Disease. - A review of the Cardiovascular Disease products under development by
Scroll down for more posts ▼

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

How Neo Pepe Coin is Capturing Investor Attention with Presale Growth

Updated Category News Views 165

Neo Pepe Coin: Breaking Ground in the Cryptocurrency World Neo Pepe Coin ($NEOP), an emergent player in the cryptocurrency landscape, has been making waves as it progresses through multiple presale stages. This new digital currency is not only attracting crypto enthusiasts but also garnering interest from larger investors or 'whales' looking for promising opportunities. A...

Continue Reading
Upcoming Conference Call for Bio-Techne's Q1 2025 Insights

Updated Category News Views 70

Upcoming Conference Call for Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) has recently announced an upcoming conference call dedicated to discussing its financial results for the first quarter of fiscal year 2025. This important event is set for a morning slot to ensure that all stakeholders can participate and gain insights into the company's performance. Details of...

Continue Reading
Modella AI's PathChat DX Receives Major FDA Recognition

Updated Category News Views 373

Modella AI's PathChat DX Achieves Breakthrough Device Designation BOSTON -- Modella AI, a pioneer in generative and agentic artificial intelligence for biomedicine, is excited to announce that its advanced generative AI co-pilot, PathChat DX, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This remarkable recognition...

Continue Reading
Nicholas Wealth Unveils New Distribution Rate for FIAX ETF

Updated Category News Views 116

Nicholas Wealth Announces New Distribution Rate for FIAX ETF Nicholas Wealth, a well-respected player in the actively managed income exchange-traded funds (ETFs) space, has revealed an exciting increase in the distribution rate for the Nicholas Fixed Income Alternative ETF (FIAX) to 8.04%. This significant change underscores their dedication to delivering strong returns...

Continue Reading
Understanding Voting Rights and Capital in Investments

Updated Category News Views 191

Understanding Total Voting Rights in Investment Firms Investors often seek clarity regarding their holdings, and a key aspect of this is understanding total voting rights and share capital. Recently, significant information was disclosed by Hargreave Hale AIM VCT PLC, and it’s worth exploring what this means. Company Overview Hargreave Hale AIM VCT PLC stands out in the...

Continue Reading